SCHEMBL2548362

SCHEMBL2548362

NCCc1nc2cnccn2c1-c1ccccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 2/20 0.37
▸ HRH1 P35367 1/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ PARP1 P09874 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ TP53 P04637 3/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ CCR1 P32246 2/20 0.33
▸ CCR5 P51681 2/20 0.33
▸ CCR8 P51685 2/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ ALPL P05186 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12264096 0.84 CYP2A6 (0.36) BRAFCYP2A6HDAC1PARP1CDK9
SCHEMBL2545743 0.77 KLK7 (0.41) HRH1MAPTKDM4ETP53TDP1
SCHEMBL2550128 0.75 PIK3CD (0.45) —
SCHEMBL12196947 0.74 PIK3CD (0.37) BRAFCYP2A6HDAC1PARP1MAPT
SCHEMBL2505110 0.74 PIK3CD (0.37) BRAFCYP2A6HDAC1PARP1MAPT
SCHEMBL108241 0.67 GABRG2 (0.47) CYP2A6HDAC1MAPTKDM4ETP53
Dipyridyl SCHEMBL16445111 0.62 KDM4E (0.74) HRH1CYP2A6MAPTKDM4ETP53
SCHEMBL840433 0.62 RAD51 (0.50) BRAFPARP1CDK9MAPTKDM4E
SCHEMBL21209650 0.61 CYP2A6 (0.47) BRAFCYP2A6HDAC1MAPTKDM4E
Dipyridyl SCHEMBL10405168 0.61 KDM4E (0.70) HRH1CYP2A6MAPTKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2552908-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2013-02-06 — — EP disclosed
WO-2011123751-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2011-10-06 — — WO disclosed
Send feedback